Shay Shemesh, Chief Development Officer at Nuvectis Pharma, Inc. (NVCT), bought 2,946 shares at $3.38 ($10K) on 2022-02-04, disclosed to the SEC on 2022-02-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.38 | 2,100 | $7K | 70.7% |
| 2 | $3.47 | 846 | $3K | 29.3% |
| Total | $3.41 avg | 2,946 | $10K | 100% |
| Filing → |
| NVCT | BUY | 2023-03-17 | $7K | — | Filing → |
| NVCT | BUY | 2022-12-22 | $4K | — | Filing → |
| NVCT | BUY | 2022-11-18 | $2K | — | Filing → |